Medical Bulletin 27/November/2021

Published On 2021-11-27T19:15:48+05:30 | Updated On 27 Nov 2021 1:45 PM GMT

Overview

Here are Top Medical stories of the day

Self-management BP tool in Smartphones

A new study conducted by Tomer Gazit and team showed that a mobile technology hypertension self-management tool can help with long-term blood pressure control and extremely high blood pressure detection. Such systems have the potential to enhance real-world BP monitoring and control.

The findings of this study were published in the Journal of American Medical Association.

For more details, check out the full story on the link below:

Self-Management Tool In Smartphones Enhances Real-World BP Monitoring And Control: JAMA

Adults with ADHD: Anxiety disorder

Obesity increases cranial nerve palsy risk

Daye Diana Choi and colleagues discovered that both general and abdominal obesity increased the incidence of cranial nerve palsies (CNP) in a retrospective cohort analysis. Furthermore, a combination of general and abdominal obesity may raise the risk of CNP. The purpose of this study was to look at the relationship between obesity and the development of third, fourth, and sixth cranial nerve palsies (CNP).

The findings of this study were published in the American Journal of ophthalmology on 17th September 2021.

For more details, check out the full story on the link below:

Obesity Increases Risk Of Cranial Nerve Palsies: Study

Bentracimab safe to reverse Ticagrelor's effects

Bentracimab, an intravenous reversal agent for ticagrelor, has shown immediate and sustained reversal of the Tiacgrelor's antiplatelet effects in both patients undergoing surgery and those with major bleeding, according to a prespecified interim analysis of the REVERSE-IT study presented this week at AHA, 2021.

The drug is a recombinant IgG1 monoclonal antibody fragment that binds to both ticagrelor and its major active circulating metabolite, reversing the antiplatelet effects within 5 minutes. Previous phase I data in healthy participants, published in 2019, sparked excitement as a potential answer to the challenges faced not just by surgeons, but also by physicians when patients on ticagrelor present with an intracranial hemorrhage, for example, and can't wait the recommended 5 days for the drug's effects to wear off.

For more details, check out the full story on the link below:

AHA 2021: Bentracimab Rapid And Safe To Reverse Ticagrelor's Effects, REVERSE IT Study

Hypoglycemic crisis in dialysis patients

Speakers

Dr. Nandita Mohan

Dr. Nandita Mohan is a practicing pediatric dentist with more than 3 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped.